Pipeline

Antabio portfolio

DISCOVERY

PRECLINICAL

PHASE 1

PHASE 2

PHASE 3

MEM-PIL

Meropenem-Pilabactam
CRAB, CRE, PA
IV
HAP/VAP

PEi

Pseudomonas Elastase Inhibitors
PA
Inhaled
Chronic respiratory diseases

AGAR-dp

Antabio-GARDP discovery platform

3 projects, novel MoA
IV / Oral stepdown
HAP/VAP, cUTI

in collaboration with

INTABIO-dp

Antabio internal discovery platform

1 project, novel target
IV / Oral stepdown
HAP/VAP, cUTI